Literature DB >> 19458332

Complex antibody profile changes in an experimental autoimmune glaucoma animal model.

Stephanie C Joachim1, Franz H Grus, Daniela Kraft, Kisha White-Farrar, George Barnes, Mike Barbeck, Shahram Ghanaati, Shutong Cao, Byron Li, Martin B Wax.   

Abstract

PURPOSE: Increased serum antibodies against heat shock protein 27 (HSP27) have been identified in patients with glaucoma. Immunization with HSP27 caused retinal ganglion cell (RGC) loss in animals. The authors analyzed whether HSP27 immunization not only causes RGC loss but also affects systemic antibody patterns.
METHODS: Rats were immunized with HSP27 and were surveyed for 4, 5, and 6 weeks (groups 1-3). Control animals were humanely killed after 6 weeks (group 4). Intraocular pressure was measured before and 2 and 4 weeks after immunization. Fundus images were taken at the same time. Retinal flatmounts were prepared, and Brn-3a labeled RGCs were counted. Serum was collected during the study to detect antibody patterns against retinal antigens through Western blot analysis and mass spectrometry techniques. Patterns were analyzed by multivariate statistical techniques, and biomarkers were identified with the use of mass spectrometry.
RESULTS: No significant changes in intraocular pressure were observed, and no fundus abnormalities were noted. The animals immunized with HSP27 showed lower RGC density than controls (P < 0.05). Two and 4 weeks after immunization, we detected a significant difference in antibody profiles between groups 1 and 4 (P < 0.05) and groups 3 and 4 (P < 0.05). Proteins with different antibody level expression after immunization included heat shock protein 90, alpha-enolase, and glyceraldehyde-3-phosphate dehydrogenase.
CONCLUSIONS: After immunization with HSP27, animals showed IOP-independent RGC loss and changes in serum antibody patterns. Thus, this model might be a beneficial approach to study the development and effects of anti-retinal antibodies and their involvement in RGC loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458332     DOI: 10.1167/iovs.08-3144

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

1.  Biomarkers for glaucoma: from the lab to the clinic.

Authors:  N Von Thun Und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

3.  [Complement activation after induction of ocular hypertension in an animal model].

Authors:  S Becker; S Reinehr; H Burkhard Dick; S C Joachim
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

Review 4.  Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.

Authors:  Natik Piri; Jacky M K Kwong; Lei Gu; Joseph Caprioli
Journal:  Prog Retin Eye Res       Date:  2016-03-24       Impact factor: 21.198

Review 5.  The immune response in glaucoma: a perspective on the roles of oxidative stress.

Authors:  Gülgün Tezel
Journal:  Exp Eye Res       Date:  2010-08-13       Impact factor: 3.467

Review 6.  [Basic biochemical processes in glaucoma progression].

Authors:  N von Thun und Hohenstein-Blaul; S Kunst; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

7.  Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions.

Authors:  Stephanie C Joachim; Christine Mondon; Oliver W Gramlich; Franz H Grus; H Burkhard Dick
Journal:  J Mol Neurosci       Date:  2013-10-03       Impact factor: 3.444

8.  Western blot patterns of serum autoantibodies against optic nerve antigens in dogs with goniodysgenesis-related glaucoma.

Authors:  Stephanie A Pumphrey; Stefano Pizzirani; Christopher G Pirie; M Sawkat Anwer; Tanya Logvinenko
Journal:  Am J Vet Res       Date:  2013-04       Impact factor: 1.156

9.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

Review 10.  Immune regulation toward immunomodulation for neuroprotection in glaucoma.

Authors:  Gülgün Tezel
Journal:  Curr Opin Pharmacol       Date:  2012-10-19       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.